Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Korean researchers describe new ginseng saponins with antitumor activity

Nov. 7, 1997

Safety of nemorubicin (daily x 3 every 28 days) evaluated in phase I trial

Nov. 6, 1997

New camptothecin analogues synthesized at U of Michigan

Nov. 5, 1997

Bristol-Myers Squibb prepares protein farnesyltransferase inhibitors

Nov. 4, 1997

Inhibition of human pancreatic cancer invasion and metastasis by serine protease inhibitor

Nov. 3, 1997

Grant supports p53 gene research at The Wistar Institute

Nov. 3, 1997

Initial results show Ethyol effective in reducing radiation-induced xerostomia

Nov. 3, 1997

Promising interim safety and efficacy data reported for Gd-Tex

Nov. 3, 1997

First oral, tumor-activated anticancer drug filed by Roche

Oct. 31, 1997

Temozolomide: phase II efficacy and tolerability data in patients with high-grade glioma

Oct. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...